| Specialty Retail Industry | Consumer Discretionary Sector | Jason R. Tucker CEO | OTC PINK Exchange | 13764N207 CUSIP |
| US Country | 1 Employees | - Last Dividend | 13 Nov 2020 Last Split | - IPO Date |
Cann American Corp., originally founded as Canamed4Pets, Inc., transitioned its corporate identity in December 2019 to reflect a broader mission within the healthcare sector. Established in 2004 and headquartered in Orlando, Florida, this development stage company has dedicated itself to revolutionizing healthcare solutions. By focusing on innovative therapies, Cann American Corp. strives to make healthcare not only more affordable but also more accessible to a wide range of patients. The company leverages cutting-edge technology with the aim of reducing healthcare costs while simultaneously improving the quality and availability of healthcare services, ensuring that high-quality care is within reach for all patients.
Cann American Corp. is actively engaged in the development and implementation of a variety of products and services designed to fulfill its mission of advancing healthcare solutions: